Document is current
Any future updates will be listed below
-
Authors
Spira, Alexander I.
Ran, Tao
Lin, Iris
Chen, Cindy
He, Andy
Belani, Neel
Du, Shawn
-
Funding
Funding for this research was provided by:
Janssen Scientific Affairs, LLC, a Johnson & Johnson company
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 2 May 2025
First Online: 29 May 2025
Declarations
:
: Alexander I. Spira is an employee of Virginia Cancer Specialists and has received consulting fees from Johnson & Johnson. Tao Ran, Iris Lin, Cindy Chen, Andy He, and Shawn Du are employees and stockholders of Johnson & Johnson. Neel Belani is an employee of Virginia Cancer Specialists.
: The data were de-identified and subject to obligations to prevent re-identification and protect patient confidentiality. Permission was obtained from Flatiron Health to use the data in this study. The datasets generated and/or analyzed during the current study are not publicly available because the data that support the findings of this study were originated by and are the property of Flatiron Health, Inc. and Foundation Medicine, Inc., which have restrictions prohibiting the authors from making the dataset publicly available.
